← Eichor
Study identifier: NCT06820515 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ATHNdataset Registry

Condition: Hemophilia · Thrombosis · Hemophilia A  ·  Sponsor: American Thrombosis and Hemostasis Network

PhaseN/A
Planned participants200000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems. Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.

This description comes directly from the study's public registry record.

Talk to the study team

Emily Callegari, RN  ·  8003602846  ·  ecallegari@athn.org

Carol Fedor, RN  ·  8003602846  ·  cfedor@athn.org

Always discuss trial participation with your own doctor first.

Locations (1)

American Thrombosis and Hemostasis NetworkHickory, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06820515